These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 9540025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.
    Segal P, Feig PU, Schernthaner G, Ratzmann KP, Rybka J, Petzinna D, Berlin C.
    Diabetes Care; 1997 May; 20(5):687-91. PubMed ID: 9135927
    [Abstract] [Full Text] [Related]

  • 6. Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.
    Johnston PS, Coniff RF, Hoogwerf BJ, Santiago JV, Pi-Sunyer FX, Krol A.
    Diabetes Care; 1994 Jan; 17(1):20-9. PubMed ID: 8112185
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.
    Chiasson JL, Naditch L, Miglitol Canadian University Investigator Group.
    Diabetes Care; 2001 Jun; 24(6):989-94. PubMed ID: 11375358
    [Abstract] [Full Text] [Related]

  • 9. [The alpha-glucosidase inhibitor miglitol for the treatment of type 2 diabetes mellitus in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2001 Jul 19; 119 Suppl 2():55-61. PubMed ID: 15704357
    [Abstract] [Full Text] [Related]

  • 10. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
    Johnson AB, Taylor R.
    Diabetes Care; 1996 Jun 19; 19(6):559-63. PubMed ID: 8725851
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.
    Pagano G, Marena S, Corgiat-Mansin L, Cravero F, Giorda C, Bozza M, Rossi CM.
    Diabete Metab; 1995 Jun 19; 21(3):162-7. PubMed ID: 7556806
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. alpha-Glucosidase inhibition by miglitol in NIDDM patients.
    Kingma PJ, Menheere PP, Sels JP, Nieuwenhuijzen Kruseman AC.
    Diabetes Care; 1992 Apr 19; 15(4):478-83. PubMed ID: 1499461
    [Abstract] [Full Text] [Related]

  • 15. Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.
    Standl E, Schernthaner G, Rybka J, Hanefeld M, Raptis SA, Naditch L.
    Diabetes Res Clin Pract; 2001 Mar 19; 51(3):205-13. PubMed ID: 11269893
    [Abstract] [Full Text] [Related]

  • 16. Effects of 8-wk alpha-glucosidase inhibition on metabolic control, C-peptide secretion, hepatic glucose output, and peripheral insulin sensitivity in poorly controlled type II diabetic patients.
    Schnack C, Prager RJ, Winkler J, Klauser RM, Schneider BG, Schernthaner G.
    Diabetes Care; 1989 Sep 19; 12(8):537-43. PubMed ID: 2673693
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of type 2 diabetes mellitus with the alpha-glucosidase inhibitor Miglitol in the doctor's office].
    Fehmann HC.
    Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():55-61. PubMed ID: 15700487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.